Banque Cantonale Vaudoise reduced its position in shares of Hologic, Inc. (NASDAQ:HOLX – Free Report) by 27.1% in the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 26,127 shares of the medical equipment provider’s stock after selling 9,700 shares during the quarter. Banque Cantonale […]
Hologic (NASDAQ:HOLX – Get Free Report) had its price objective decreased by research analysts at Morgan Stanley from $86.00 to $82.00 in a report released on Monday, Benzinga reports. The brokerage presently has an “equal weight” rating on the medical equipment provider’s stock. Morgan Stanley’s price target indicates a potential upside of 14.14% from the […]
Hologic (NASDAQ:HOLX – Get Free Report) had its target price dropped by research analysts at Morgan Stanley from $86.00 to $82.00 in a research note issued to investors on Monday, Benzinga reports. The brokerage presently has an “equal weight” rating on the medical equipment provider’s stock. Morgan Stanley’s price objective would indicate a potential upside […]
Hologic (NASDAQ:HOLX – Get Free Report) issued its quarterly earnings results on Thursday. The medical equipment provider reported $0.89 earnings per share for the quarter, beating analysts’ consensus estimates of $0.84 by $0.05, Briefing.com reports. Hologic had a return on equity of 19.02% and a net margin of 11.99%. The business had revenue of $945.30 […]
SPC Financial Inc. lessened its stake in Hologic, Inc. (NASDAQ:HOLX – Free Report) by 1.9% in the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 12,686 shares of the medical equipment provider’s stock after selling 243 shares during the quarter. SPC Financial Inc.’s holdings in […]